FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics. Composition contains botulinum toxin, polysorbate 20 and methionine, where methionine is present in amount from 25 to 75 mM, and polysorbate 20 is present in amount from 0.1 to 2.5 mg/ml.
EFFECT: composition possesses improved stability; application of liquid pharmaceutical composition in form of combination of polysorbate 20 and methionine as botulinum toxin stabilisers instead of proteins of animal origin albumin and gelatin eliminates risk of organism contamination by pathogens or microorganisms of serum origin and makes it possible to introduce into organism safely; in addition, composition is convenient for application in direct introduction to patients.
8 cl, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID COMPOSITION STABILIZING BOTULINUM TOXIN | 2019 |
|
RU2812790C2 |
| LYOPHILISED PREPARATION OF BOTULINUM TOXIN | 2012 |
|
RU2574011C2 |
| LYOPHILISED PREPARATION OF BOTULINUM TOXIN | 2012 |
|
RU2640922C1 |
| COMPOSITION FOR PROTEIN PHARMACEUTICAL PREPARATION WITH NO ADDED HUMAN SERUM ALBUMIN (HSA) | 2004 |
|
RU2491927C2 |
| COMPOSITION FOR PROTEIN PHARMACEUTICAL MEDICATION WITHOUT ADDITION OF HUMAN SERUM ALBUMEN (HSA) | 2004 |
|
RU2354366C2 |
| LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE | 2017 |
|
RU2741497C2 |
| Liquid composition containing botulinum toxin and a stabilizing agent, and a method for its preparation | 2017 |
|
RU2748653C2 |
| STABILIZED NON-PROTEIN COMPOSITIONS OF CLOSTRIDIAL TOXIN | 2017 |
|
RU2762607C2 |
| PHARMACEUTICAL COMPOSITIONS OF CLOSTRIDIA TOXIN | 2009 |
|
RU2535003C2 |
| LIQUID COMPOSITION OF AN ANTIBODY AGAINST TNF ALPHA | 2018 |
|
RU2756619C2 |
